Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Deep Value
  3. /Pesticides/Agrochemicals
MomentumDeep Value

Which Pesticides/Agrochemicals Stocks Are Deep Value Picks in Week of May 17, 2026?

In the Week of May 17, 2026, the Pesticides/Agrochemicals sector has 1 stocks that are underperforming Nifty 500 but have accelerating quarterly earnings. Average value score is 23/100.

Total Stocks
1
deep value
Avg Fundamental
23
/100
Top Pick
Dhanuka
Score: 29/100
Avg Margin of Safety
Overvalued

Stock Distribution

0 Strong0 Good0 Average2 Weak

Earnings & Valuation Signals

⚠️

1 stock flagged for margin pressure — profits may not sustain.

⚠️

2 of 2 stocks trading above fair value — limited margin of safety.

AI Research Summary

Sector Pulse

The Agrochemicals and Pesticides sector is currently experiencing a tale of two markets. Export-oriented players are thriving on the back of global recovery and favorable product mixes, while domestic-focused constituents are battling severe weather-related headwinds. Overall, the demand environment is leaning towards IMPROVING, driven by international markets. SHARDACROP and 524717 (Titan Biotech) delivered explosive growth, while DHANUKA struggled with a domestic slowdown.

Catalysts Playing Out Across the Pack

The dominant narrative across the sector is Operating Leverage Inflection and Value Added Product Mix Shift. Companies are successfully pivoting away from low-margin commodities toward specialized, high-value molecules. BHAGCHEM expanded its gross margins by 311 bps to 43% through process upgrades at its Bheema facility. Similarly, SHARDACROP leveraged its massive portfolio of 3,004 global registrations to drive an 11.6% positive impact from price and product mix. Geographical Expansion is also a critical moat; SHARDACROP saw its European revenue almost double, completely insulating it from the domestic agricultural slump.

What Managements Are Guiding

Forward guidance reflects the divergence in market exposure. SHARDACROP is highly confident, raising its full-year revenue growth target to 20% and its EBITDA margin guidance to 18-20%. Conversely, DHANUKA is maintaining a cautious 'flattish' outlook for the year, banking heavily on a Q4 Rabi season recovery to offset a disastrous Q3. Capital allocation remains aggressive for the winners, with SHARDACROP committing ₹500 Cr primarily for new product registrations and BHAGCHEM investing ₹350 Cr in Phase 2 expansion, albeit with a slightly delayed commencement to H1FY28.

Sub-Sector Aggregates

The aggregate metrics reveal a sector that is highly profitable despite localized volume pressures. The YoY Revenue Growth averaged 22.4%, but this masks a wide range from DHANUKA's -7.9% contraction to 524717's 47.62% surge. More importantly, the EBITDA Margin averaged a healthy 16.1%, with 2 of 4 constituents (524717 and SHARDACROP) reporting margins above 19%. This margin resilience translated into an average YoY PAT Growth of 115.2%, proving that the shift toward value-added products is successfully protecting the bottom line.

Shared Risks (9-type taxonomy)

The sector faces three primary risks: climate, commodity, and regulatory. The climate risk is currently the most severe for domestic players; DHANUKA explicitly cited significantly extended rainfall that delayed farmer purchases and ruined the Kharif application window. On the commodity front, China's reduction of export rebates is threatening to increase input costs for technicals, forcing players like BHAGCHEM to focus on backward integration. regulatory risks also materialized, with DHANUKA taking a ₹49 Cr revenue hit due to new government guidelines banning certain biostimulants pending fresh clearances.

Bottom Line

The agrochemical space is highly lucrative for players with diversified global registrations and a focus on value-added molecules. While domestic climate risks and shifting Chinese export policies present near-term volatility, the underlying margin expansion and aggressive capex pipelines suggest the sector is structurally sound and poised for continued profitability.

Last updated Apr 19, 2026

2 stocks in this sector

View:
Weak34/100

Dhanuka Agritech Ltd

4.9K Cr
Extremely Overvalued
Earnings Pulse
PAT YoY
-27%
Declining
Revenue YoY
-8%
Momentum
Fading
▼
Margin Pressure
Very Weak11/100

Heranba Industries Ltd

—
Extremely Overvalued
Earnings Pulse
PAT YoY
-130%
Stable
Revenue YoY
-12%
Momentum
Slowing
↘

Explore More

All Deep Value SectorsMomentum Sectors← Back to Dashboard

Frequently Asked Questions: Pesticides/Agrochemicals

Based on publicly available financial data. This is educational research, not investment advice.

How many Pesticides/Agrochemicals stocks are deep value opportunities worth studying?

There are currently 1 stocks in the Pesticides/Agrochemicals sector that qualify as deep value opportunities worth studying. These stocks are underperforming the market despite showing improving earnings — a classic contrarian research signal.

Which Pesticides/Agrochemicals deep value stocks appear most undervalued?

The most undervalued Pesticides/Agrochemicals deep value stocks based on fair value analysis

  • Dhanuka Agritech Ltd — Significantly Overvalued
  • Heranba Industries Ltd — Significantly Overvalued
  • Stocks sorted by valuation signal (most undervalued first).

Which Pesticides/Agrochemicals deep value stock has the highest earnings acceleration?

Pesticides/Agrochemicals deep value stocks with the highest earnings growth

  • Dhanuka Agritech Ltd — PAT growth -27.3% YoY, earnings inflecting downward
  • Heranba Industries Ltd — PAT growth -130.0% YoY, earnings stable

Why are Pesticides/Agrochemicals stocks underperforming despite improving earnings?

Pesticides/Agrochemicals deep value stocks are underperforming despite improving earnings because the market has not yet recognized their earnings recovery. This creates a potential opportunity for patient investors

  • The market often takes 2-4 quarters to re-rate stocks after earnings improve
  • Deep value stocks typically have a negative narrative that suppresses sentiment
  • Improving earnings combined with market underperformance creates a valuation gap
  • When the market eventually recognizes the recovery, re-rating can be significant
  • This is an educational explanation of deep value investing theory.

Which Pesticides/Agrochemicals deep value stocks have the highest revenue growth?

Pesticides/Agrochemicals deep value stocks with the highest revenue growth

  • Dhanuka Agritech Ltd — Revenue growth -7.9% YoY
  • Heranba Industries Ltd — Revenue growth -11.7% YoY

What is the average PE ratio of Pesticides/Agrochemicals deep value stocks?

The average PE ratio of Pesticides/Agrochemicals deep value stocks is 15.6x. Deep value stocks typically trade at lower PE multiples relative to their sector peers, reflecting the market's skepticism about their recovery.

Is the earnings recovery in Pesticides/Agrochemicals sustainable?

Sustainability indicators for the Pesticides/Agrochemicals deep value earnings recovery

  • A sustainable recovery shows more stocks accelerating than decelerating.

Is Pesticides/Agrochemicals a contrarian opportunity worth studying?

Pesticides/Agrochemicals as a contrarian opportunity — key research signals

  • 1 stocks underperforming the market (contrarian setup)
  • Contrarian investing requires patience.

What is the typical recovery timeline for deep value stocks?

Deep value stock recovery timelines vary, but historical patterns suggest

  • 1-2 quarters: Earnings inflection detected, market still skeptical
  • 2-4 quarters: Consistent earnings improvement builds confidence
  • 4-6 quarters: Market re-rates, stock price catches up to fundamentals
  • Some stocks never recover — continuous monitoring is essential
  • Timelines are approximate and based on historical patterns.

What is deep value investing?

Deep value investing is a strategy of studying stocks that are underperforming the market despite showing improving fundamentals (earnings growth, margin expansion). The thesis is that the market has not yet recognized the earnings recovery, creating a potential valuation gap.

  • These stocks typically underperform indices like Nifty 500
  • They show positive earnings trends (PAT growth, revenue growth)
  • The market eventually re-rates them as earnings improvements sustain
  • It requires patience — recovery can take several quarters

The above FAQs are based on publicly available financial data. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.